Non-Stimulant Medications in the Treatment of Attention-Deficit Hyperactivity Disorder.
- Author:
Jun Won HWANG
1
Author Information
1. Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul Metropolitan Eunpyeong Hospital, Seoul, Korea. huangjw@hanmail.net
- Publication Type:Review
- Keywords:
Attention-Deficit Hyperactivity Disorder;
Atomoxetine;
Bupropion;
Modafinil
- MeSH:
Benzhydryl Compounds;
Bupropion;
Child;
Comorbidity;
Humans;
Propylamines;
Atomoxetine Hydrochloride
- From:Journal of the Korean Academy of Child and Adolescent Psychiatry
2008;19(2):72-82
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The aim of this paper is to evaluate the use of non-stimulants, including atomoxetine, bupropion and modafinil, as alternative approaches to the treatment of children with attention-deficit hyperactivity disorder. A comprehensive review of the empirically based literature regarding the efficacy and the safety of the non-stimulants was performed. There is a large and increasing body of data supporting the efficacy and the safety of non-stimulants. Although the treatment effect sizes for non-stimulants may be smaller than those for stimulants, non-stimulants alone have been shown to be effective in the treatment of attention-deficit hyperactivity disorder as well as several comorbidities. These results suggest that nonstimulants are effective in the treatment of attention-deficit hyperactivity disorder. Further studies are needed to improve our understanding of alternative pharmacological medications in the treatment of attention-deficit hyperactivity disorder.
